Natriuretic peptide receptor 3 genotype modulates the relationship between B-type natriuretic peptide and left ventricular end-diastolic pressure

Therapy

Volumn 3, Issue 6, 2006, Pages 765-771

  Lanfear, David E ^a   Stolker, Joshua M ^b   Marsh, Sharon ^b   Rich, Michael W ^b   McLeod, Howard L ^c  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

B type natriuretic peptide; Genetic polymorphisms; Left ventricular end diastolic pressure; Natriuretic peptide receptor 3

Indexed keywords

ADENINE; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYTOSINE; DNA; GUANINE; TYROSINE;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DNA EXTRACTION; EUROPEAN AMERICAN; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERTENSION; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PROGNOSIS; RACE DIFFERENCE;

EID: 33845413425     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.6.765     Document Type: Article

References (26)

1. McCullough PA, Philbin EF, Spertus JA et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J. Am. Coll. Cardiol. 39(1), 60-69 (2002).
2. Heart Disease and Stroke Statistics - 2005 Update. American Heart Association, 2004.
3. Jessup M, Brozena S. Heart failure. N. Eyl. J. Med 348(20), 2007-2018 (2003).
4. Chen HH, Burnett JC Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc. Assoc Am. Physicians 111(5), 406-416 (1999)
5. Stolker JM, Rich MW. B-type natriuretic peptide provides independent and incremental value in predicting left ventricular end-diastolic pressure in elderly patients. Am. J. Geriatr Cardiol. 14(2 Suppl.), 109 (2005).
6. Stolker IM, Rich MW. The combination of B-type natriuretic peptide and C-reactive protein provides incremental value in predicting outcomes among older patients referred for cardiac catheterization. Am. J. Geriatr. Cardiol. 14(2), 109-110 (2005).
7. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 362(9380), 316-322 (2003).
8. Drazner MH, de Lemos JA. Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise. Am. Heart J. 149(2), 187-9 (2005).
9. Troughton RW, Prior DL, Pereira JJ et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J. Am. Coll. Cardiol. 43(3), 416-422 (2004).
10. Nabel EG. Cardiovascular disease. N. Engl. J. Med. 349(1), 60-72 (2003).
11. Evans WE, McLeod HL. Pharmacogenomics - drug disposition, drug targets, and side effects. N. Engl. J. Med. 348(6), 538-549 (2003).
12. Wang TJ, Larson MG, Levy D et al. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108(1), 13-16 (2003).
13. Lanfear DE, Marsh S, McLeod HL. Sequence variants of natriuretic peptide receptor C are common and their frequency differs between African Americans and European Americans. J. Card. Fail. 10(4 Suppl.), S59 (2004).
14. Rehemudula D, Nakayama T, Soma M et al. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ. Res. 84(5), 605-610 (1999).
15. Rahmutula D, Nakayama T. Soma M et al. Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine 17(2), 85-90 (2002).
16. Rahmutula D, Nakayama T, Soma M et al. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J. Hum. Hypertens. 15(7), 471-474 (2001).
17. Knowles JW, Erickson LM, Guy VK et al. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum. Genet. 112(1), 62-70 (2003).
18. Nakayama T, Soma M, Saito S et al. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Med Sai. Monit. 9(12), CR505-CR510 (2003).
19. Pitzalis MV, Sarzani R, Dessi-Fulgheri P et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J. Hypertens. 21(8), 1491-1496 (2003).
20. Nakayama T, Soma M, Takahashi Y et al. Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ. Res., 86(8), 841-845 (2000).
21. Freimuth RR, Stormo GD, McLeod HL. PolyMAPr: programs for polymorphism database mining, annotation, and functional analysis. Hum. Mutat. 25(2), 110-107 (2005).
22. Marsh S, King CR, Garsa AA, McLeod HL. Pyrosequencing of clinically relevant polymorphisms. Methods Mol. Biol. 311, 97-114 (2005).
23. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet 70(2), 425-434 (2002).
24. Sandelin A, Alkema W, Engstrom P. Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
25. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13), 3568-3571 (2003).
26. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111(12), 1487-1491 (2005).